Nutromics receives FDA Breakthrough Device Designation

Posted on by sHq_LoGiNz

MELBOURNE, Australia & SAN DIEGO–(BUSINESS WIRE)–The FDA has granted Nutromics Breakthrough Device Designation for its first product in development – a wearable for vancomycin TDM.

Posted in UncategorizedTagged
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.